Literature DB >> 30936293

The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Julie Boucau1, Julien Madouasse1, Georgio Kourjian1, Christopher S Carlin1, Daniel Wambua1, Matthew J Berberich1, Sylvie Le Gall2.   

Abstract

CD4 T cell activation is critical to the initiation of adaptive immunity. CD4 T cells are also the main targets of HIV infection, and their activation status contributes to the maintenance and outcome of infection. Although the role of activation in the differentiation and proliferation of CD4 T cells is well studied, its impact on the processing and MHC class I (MHC-I) presentation of epitopes and immune recognition by CD8 T cells are not investigated. In this study, we show that the expression and hydrolytic activities of cellular peptidases are increased upon TCR-dependent and MHC-peptide activation of primary CD4 T cells from healthy or HIV-infected persons. Changes in peptidase activities altered the degradation patterns of HIV Ags analyzed by mass spectrometry, modifying the amount of MHC-I epitopes produced, the antigenicity of the degradation products, and the coverage of Ags by degradation peptides presentable by MHC-I. The computational analysis of 2237 degradation peptides generated during the degradation of various HIV-antigenic fragments in CD4 T cells identified cleavage sites that were predictably enhanced, reduced, or unchanged upon cellular activation. Epitope processing and presentation by CD4 T cells may be modulated by the activation state of cells in a sequence-dependent manner. Accordingly, cellular activation modified endogenous Ag processing and presentation and killing of HIV-infected CD4 T cells by CD8 T cells in a way that mirrored differences in in vitro epitope processing. The clearance of HIV-infected cells may rely on different immune responses according to activation state during HIV infection.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30936293      PMCID: PMC6504579          DOI: 10.4049/jimmunol.1700950

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.

Authors:  Yolanda Samino; Daniel López; Sara Guil; Loredana Saveanu; Peter M van Endert; Margarita Del Val
Journal:  J Biol Chem       Date:  2006-01-06       Impact factor: 5.157

2.  Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions.

Authors:  Michal Bassani-Sternberg; David Gfeller
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

3.  Kinetic assessment of general gene expression changes during human naive CD4+ T cell activation.

Authors:  Krista Hess; Yinhua Yang; Susanne Golech; Alexei Sharov; Kevin G Becker; Nan-Ping Weng
Journal:  Int Immunol       Date:  2004-10-18       Impact factor: 4.823

Review 4.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

5.  An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Authors:  P André; M Groettrup; P Klenerman; R de Giuli; B L Booth; V Cerundolo; M Bonneville; F Jotereau; R M Zinkernagel; V Lotteau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Authors:  Liang Shan; Kai Deng; Neeta S Shroff; Christine M Durand; S Alireza Rabi; Hung-Chih Yang; Hao Zhang; Joseph B Margolick; Joel N Blankson; Robert F Siliciano
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

8.  The carboxypeptidase ACE shapes the MHC class I peptide repertoire.

Authors:  Xiao Z Shen; Sandrine Billet; Chentao Lin; Derick Okwan-Duodu; Xu Chen; Aron E Lukacher; Kenneth E Bernstein
Journal:  Nat Immunol       Date:  2011-10-02       Impact factor: 25.606

9.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.

Authors:  Kai Deng; Mihaela Pertea; Anthony Rongvaux; Leyao Wang; Christine M Durand; Gabriel Ghiaur; Jun Lai; Holly L McHugh; Haiping Hao; Hao Zhang; Joseph B Margolick; Cagan Gurer; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Steven G Deeks; Till Strowig; Priti Kumar; Janet D Siliciano; Steven L Salzberg; Richard A Flavell; Liang Shan; Robert F Siliciano
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

Review 10.  Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Authors:  Marijana Rucevic; Julie Boucau; Jens Dinter; Georgio Kourjian; Sylvie Le Gall
Journal:  Viruses       Date:  2014-08-21       Impact factor: 5.048

View more
  4 in total

1.  Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal.

Authors:  Talia M Mota; Chase D McCann; Ali Danesh; Szu-Han Huang; Dean B Magat; Yanqin Ren; Louise Leyre; Tracy D Bui; Thomas M Rohwetter; Colin M Kovacs; Erika Benko; Lynsay MacLaren; Avery Wimpelberg; Christopher M Cannon; W David Hardy; Jeffrey T Safrit; R Brad Jones
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation.

Authors:  Yang-Hui Jimmy Yeh; Katharine M Jenike; Rachela M Calvi; Jennifer Chiarella; Rebecca Hoh; Steven G Deeks; Ya-Chi Ho
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Altered T-Cell Subsets are Associated with Dysregulated Cytokine Secretion of CD4+ T Cells During HIV Infection.

Authors:  Di Wang; Yu Jiang; Yangzi Song; Yongqin Zeng; Cuilin Li; Xinyue Wang; Ying Liu; Jiang Xiao; Yaxian Kong; Hongxin Zhao
Journal:  J Inflamm Res       Date:  2021-10-07

4.  Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.

Authors:  Julie Boucau; Jishnu Das; Neelambari Joshi; Sylvie Le Gall
Journal:  PLoS Pathog       Date:  2020-03-20       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.